Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04328207 · ClinicalTrials.gov registry record · NA

Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
900
Enrollment target

NCT04328207 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 900 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04328207, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
900 participants
Enrollment target

Study Summary

Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform to manage this disease in community-based clinics so that further vision loss is prevented. Our goal is to improve the quality and accessibility of glaucoma detection and management among a vulnerable and at-risk segment of our population.

Interventions

  • BEHAVIORAL Financial Incentive
  • OTHER No Financial Incentive

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2020-11-18
Est. Completion 2024-07-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04328207

The ClinicalTrials.gov registry entry for NCT04328207 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Financial Incentive is the first listed.

NCT04328207 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04328207 about?

NCT04328207 is a clinical study titled "Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits". Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and t...

What is the current status of trial NCT04328207?

This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2020-11-18. Estimated completion is 2024-07-01.

What interventions are being tested in trial NCT04328207?

The interventions under investigation include: Financial Incentive (BEHAVIORAL), No Financial Incentive (OTHER).

Who is sponsoring clinical trial NCT04328207?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.